Completed
Technological advances and the increasing availability of genomic data and computational systems have resulted in new methods to systematically identify both drug targets and pathways for detecting drugs with a secondary, often times seemingly unrelated, indication. The Roundtable on Translating Genomic-Based Research for Health hosted a workshop to assess the current landscape of drug repurposing activities in industry, academia, and government, examine enabling tools and technology, and evaluate the business models and economic incentives for drug repurposing programs.
Featured publication
Drug Repurposing and Repositioning: Workshop Summary
Proceedings
·2014
Drug development can be time-consuming and expensive. Recent estimates suggest that, on average, it takes 10 years and at least $1 billion to bring a drug to market. Given the time and expense of developing drugs de novo, pharmaceutical companies have become increasingly interested in finding new us...
View details